findmyKOL

Philip Ludbrook, MD

Basic profile

Washington University in St. Louis

ORCIDNone on fileNPI
RegionSaint Louis, MO · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Last active 1998findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1998Online presenceNot yet checkedPaymentsNone reportedNIH funding1985–1989Why? →

Philip Ludbrook is a Cardiology physician affiliated with Washington University in St. Louis. OpenAlex indexes 8 publications with 3,173 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Distinct works indexed by OpenAlex.

3,173citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
3NIH grants · 1985–1989

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4921 Parkview Pl
Div Im Cardiology, Ste 8b
Saint Louis, MO 631101032

Telephone

314-362-1291

Registry record last updated 17 Apr 2025.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    53.2%
    Angiotensin receptor blocker (ARB)19.9%
    Losartan Potassium100%
    Part D<11 patients
    Calcium channel blocker15.4%
    Amlodipine Besylate100%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    15.4%
    Factor Xa inhibitor15.4%
    Eliquis100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    15.4%
    Potassium supplement15.4%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)97.5% facility · 2.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 19851989 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”